A systematic review protocol to evaluate the psychometric properties of measures of function within adult neuro-rehabilitation

Systematic Reviews

Volumn 4, Issue 1, 2015, Pages

  Pike, Shannon ^a,b   Lannin, Natasha Anne ^a,c   Cusick, Anne ^d   Wales, Kylie ^e   Turner Stokes, Lynne ^f,g   Ashford, Stephen ^f,g  

^a LA TROBE UNIVERSITY   (Australia)

^b Wagga Wagga Research Centre   (Australia)

^c Occupational Therapy Department   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f NORTHWICK PARK HOSPITAL   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Activity performance; Botulinum toxin; Neuro rehabilitation; Outcome measurement; Participation; Upper limb

Indexed keywords

ARTICLE; DATA ANALYSIS; HUMAN; INFORMATION PROCESSING; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOMETRY; REHABILITATION CARE; SPASTICITY; SYSTEMATIC REVIEW (TOPIC); ADULT; BRAIN INJURIES; CLINICAL PROTOCOL; COMPLICATION; METHODOLOGY; MUSCLE SPASTICITY; STATISTICS AND NUMERICAL DATA;

ADULT; BRAIN INJURIES; CLINICAL PROTOCOLS; HUMANS; MUSCLE SPASTICITY; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; RESEARCH DESIGN;

EID: 84939161305     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-015-0076-5     Document Type: Article

References (29)

1. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: Disordered Motor Control. Miami: Symposia Specialists; 1980. p. 485-94.
2. Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Buridge J, et al. Spasticity: clinical perception, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27(1/2):2-6.
3. World Health Organisation. International Classification of Functioning, Disability and Health. Geneva: World Health Organisation; 2001.
4. Ashford S, Turner-Stokes L. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity. Physiother Res Int. 2013;18(3):178-89. doi:10.1002/pri.1554.
5. Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity (review). Cochrane Database Syst Rev. 2013;6:CD009689. doi:10.1002/14651858.CD009689.pub2.
6. Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17 Suppl 2:74-93.
7. Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapists Interested in Neurology. Spasticity in adults: management using botulinum toxin. National guidelines. London: RCP; 2009.
8. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23:362-70. doi:10.1177/0269215508101742.
9. Playford ED, Siegert R, Levack W, Freeman J. Areas of consensus and controversy about goal setting in rehabilitation: a conference report. Clin Rehabil. 2009;23:334-44. doi:10.1177/0269215509103506.
10. Rosewilliam S, Roskell CA, Pandyan AD. A systematic review and synthesis of the quantitative and qualitative evidence behind patient-centred goal setting in stroke rehabilitation. Clin Rehabil. 2011;25(6):501-14.
11. Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P. Results from the Upper Limb International Spasticity Study-II (ULISII): a large international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management. BMJ Open. 2013;3:e002771.
12. Ward AB, Aguilar M, De Beryl Z, Gedin S, Kanovsky P, Molteni F, et al. Use of botulinum toxin type A in management of adult spasticity-a European consensus statement. J Rehabil Med. 2003;35:98-9.
13. William G, Olver J, de Graaff S, Singer BJ. The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals. Aust Occup Ther J. 2012;59:257-64.
14. Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, et al. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. Int J Rehabil Res. 2010;33(3):191-204.
15. Ashford S, Slade M, Malaprade F, Turner-Stokes L. Evaluation of functional outcome measures for the hemiparetic upper limb: a systematic review. J Rehabil Med. 2008;40:787-95.
16. Intiso D, Simone V, Di Rienzo F, Santamato A, Russo M, Tolfa M, et al. Does spasticity reduction by botulinum toxin type A improve upper limb functionality in adult post-stroke patients? A systematic review of relevant studies. J Neurol Neurophysiol. 2013;4(4):167.
17. Sheean GL. Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol. 2001;14:771-6.
18. Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. Mov Disord. 2009;24(6):801-12.
19. Cusick A, Lannin NA, Kinnear B: Upper limb spasticity management for patients who have received botulinum toxin A injection: Australian therapy practice. Australian Occupational Therapy Journal, in press.
20. Turner-Stokes L, Baguley IJ, de Graaff S, Katrak P, Davies L, McCrory P, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo controlled randomised clinical trial. J Rehabil Med. 2010;42:81-9.
21. Hinderer SR, Gupta S. Functional outcome measures to assess interventions for spasticity. Arch Phys Med Rehabil. 1996;77:1083-9.
22. Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil. 2005;27(1/2):7-18.
23. Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691-8.
24. Shaw LC, Price CIM, van Wijck FMJ, Shackley P, Steen N, Barnes MP, et al. Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain. Stroke. 2011;42:1371-9.
25. Terwee CB, Jansma EP, Riphagen II, de Vet HC. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18:1115e23.
26. De Vet HC, Terwee CB, Mokkink LB, Knol DL. Systematic reviews of measurement properties. In: De Vet HCW, Terwee CB, Mokkink LB, Knol DL, editors. Measurement in Medicine: A practical guide. New York: Cambridge University Press; 2011. p. 275-314.
27. Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21:651-7. doi:10.1007/s11136-011-9960-1.
28. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37:212-8.
29. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34-42.